You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME/CE

Chocolate Intake Benefits the Heart and Brain

  • Authors: News Author: Michael O'Riordan
    CME Author: Penny Murata, MD
  • CME/CE Released: 9/6/2011
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 9/6/2012
Start Activity


Target Audience and Goal Statement

This article is intended for primary care clinicians, cardiologists, endocrinologists, and other specialists who provide care to persons at risk for cardiometabolic disorders.

The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.

Upon completion of this activity, participants will be able to:

  1. Report whether chocolate intake is related to the risk for cardiometabolic disorders overall.
  2. Report whether chocolate intake is related to the risk for cardiovascular disease, diabetes, stroke, and heart failure.


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Michael O'Riordan

    Michael O'Riordan is a journalist for Medscape. Before becoming a journalist for theheart.org, now part of the WebMD Professional Network, he worked for WebMD Canada. Michael studied at Queen's University in Kingston and the University of Toronto and has a master's degree in journalism from the University of British Columbia, where he specialized in medical reporting. He can be contacted at [email protected]

    Disclosures

    Disclosure: Michael O'Riordan has disclosed no relevant financial relationships.

Editor(s)

  • Brande Nicole Martin

    CME Clinical Editor, Medscape, LLC

    Disclosures

    Disclosure: Brande Nicole Martin has disclosed no relevant financial relationships.

CME Author(s)

  • Penny Murata, MD

    Clinical Professor, Pediatrics, University of California, Irvine, California
    Pediatric Clerkship Director, University of California, Irvine, California

    Disclosures

    Disclosure: Penny Murata, MD, has disclosed no relevant financial relationships.

CME Reviewer(s)

  • Sarah Fleischman

    CME Program Manager, Medscape, LLC

    Disclosures

    Disclosure: Sarah Fleischman has disclosed no relevant financial relationships.

Nurse Planner

  • Laurie E. Scudder, DNP, NP

    Nurse Planner, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC

    Disclosures

    Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only credit commensurate with the extent of their participation in the activity.

    This enduring material activity, Medscape Education Clinical Briefs, has been reviewed and is acceptable for up to 300 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins September 1, 2011. Term of approval is for 1 year from this date. Each Clinical Brief is approved for .25 Prescribed credits. Credit may be claimed for 1 year from the date of each Clinical Brief. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Note: Total credit is subject to change based on topic selection and article length.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    AAFP Accreditation Questions

    Contact This Provider

    For Nurses

  • Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Awarded 0.5 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.

    Accreditation of this program does not imply endorsement by either Medscape, LLC or ANCC.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. MedscapeCME encourages you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CME/CE

Chocolate Intake Benefits the Heart and Brain

Authors: News Author: Michael O'Riordan CME Author: Penny Murata, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME/CE Released: 9/6/2011

Valid for credit through: 9/6/2012

processing....

Clinical Context

According to Ogbera in the January 12, 2010, issue of Diabetology & Metabolic Syndrome, approximately one fifth of adults worldwide are likely to have metabolic syndrome, a set of factors linked with a greater risk for type 2 diabetes and cardiovascular disease. The consumption of chocolate might be beneficial in the prevention of cardiometabolic disorders. A study by Allen and colleagues in the April 2008 issue of the Journal of Nutrition found that daily chocolate consumption had a positive effect on cardiovascular risk factors.

This meta-analysis by Buitrago-Lopez and colleagues assesses the association between chocolate intake and the risk for cardiometabolic disorders overall, in addition to the risk for cardiovascular disease, diabetes, stroke, and heart failure.

Study Synopsis and Perspective

In a city renowned for its love of food, it is only fitting that researchers presented the results of a new study in Paris, France, showing that chocolate is good for the heart and brain. In a presentation at the European Society of Cardiology (ESC) 2011 Congress, British investigators are reporting that individuals who ate the most chocolate had a 37% lower risk of cardiovascular disease and a 29% lower risk of stroke compared with individuals who ate the least amount of chocolate.

In the study, published online August 29, 2011 in BMJ to coincide with the ESC presentation, Dr Adriana Buitrago-Lopez (University of Cambridge, UK) and colleagues state: "Although overconsumption can have harmful effects, the existing studies generally agree on a potential beneficial association of chocolate consumption with a lower risk of cardiometabolic disorders. Our findings confirm this, and we found that higher levels of chocolate consumption might be associated with a one-third reduction in the risk of developing cardiovascular disease."

In this meta-analysis of six cohort studies and one cross-sectional study, overall chocolate consumption was reported, with investigators not differentiating between dark, milk, or white chocolate. Chocolate in any form was included, such as chocolate bars, chocolate drinks, and chocolate snacks, such as confectionary, biscuits, desserts, and nutritional supplements. Chocolate consumption was reported differently in the trials but ranged from never to more than once per day. Most patients included in the trials were white, although one study included Hispanic and African Americans and one study included Asian patients.

Of the seven studies, five trials reported a significant inverse association between chocolate intake and cardiometabolic disorders. For example, individual studies showed reductions in the risk of coronary heart disease (odds ratio 0.43; 95% CI 0.27–0.68), the risk of cardiovascular disease mortality (relative risk [RR] 0.50; 95% CI 0.32–0.78), and the risk of incident diabetes in men (hazard ratio 0.65; 95% CI 0.43–0.97).

Overall, the pooled meta-analysis results showed that high levels of chocolate consumption compared with the lowest levels of chocolate consumption reduced the risk of any cardiovascular disease 37% (RR 0.63; 0.44–0.90) and stroke 29% (RR 0.71; 0.52–0.98). There was no association between chocolate consumption and the risk of heart failure, and no association on the incidence of diabetes in women.

The researchers note that the findings corroborate the results of previous meta-analyses of experimental and observational studies in different populations showing a similar relationship between chocolate and cocoa consumption and cardiometabolic disorders.

"These favorable effects seem mainly mediated by the high content of polyphenols present in cocoa products and are probably accrued through the increasing bioavailability of nitric oxide, which subsequently might lead to improvements in endothelial function, reductions in platelet function, and additional beneficial effects on blood pressure, insulin resistance, and blood lipids," conclude Buitrago-Lopez and colleagues.

References

  1. Buitrago-Lopez A, Sanderson J, Johnson L, et al. Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. BMJ 2011; DOI:10.1136/bmj.d4488. Available at: http://www.bmj.com.

Related Link
The Centers for Disease Control and Prevention's Division for Heart Disease and Stroke Prevention aggregates information from a range of sources and provides numerous downloadable materials helpful for patient education.

Study Highlights

  • The investigators identified 4576 articles from MEDLINE (from 1950), EMBASE (from 1980), the Cochrane Library (from 1960), Scopus (from 1996), Scielo (from 1997), Web of Knowledge (from 1970), AMED (from 1985), and CINHAL (from 1981) through October 5, 2010; reference lists; and contact with authors for other articles.
  • Inclusion criteria were randomized controlled trials, cohort, case-control, or cross-sectional studies; adult participants 18 years or older; study of the effects of levels of chocolate intake; outcomes related to cardiometabolic disorders; and no language restriction.
  • Cardiometabolic disorders included cardiovascular disease, myocardial infarction, stroke, ischemic heart disease, heart failure, diabetes, and metabolic syndrome.
  • Exclusion criteria were pregnant participants in studies and use of nonhuman subjects. Types of articles excluded were letters, abstracts, systematic reviews, meta-analysis, ecologic studies, and conference proceedings.
  • 7 studies with 114,009 participants were included in the analysis.
  • 6 were cohort studies, and 1 was cross-sectional.
  • 6 studies occurred in the community, and 1 occurred in the hospital inpatient setting.
  • The age range of participants was 25 to 93 years, and most participants were white.
  • In each study, the group with the highest chocolate intake was compared vs the group with the lowest chocolate intake.
  • Intake of chocolate bars, drinks, and snacks was assessed by food frequency questionnaires in 6 studies and by patient diaries plus dietary history in 1 study.
  • The reported outcomes included myocardial infarction, diabetes, cardiovascular disease, coronary heart disease, heart failure, and stroke.
  • No studies assessed metabolic syndrome as an outcome.
  • Follow-up ranged from 8 to 16 years for the cohort studies.
  • Analyses adjusted for age, sex, body mass index, physical activity, smoking, dietary factors, and education.
  • Higher chocolate intake was linked with a decreased risk for cardiometabolic disorders in 5 of 7 studies.
  • Higher chocolate intake was beneficial in the prevention of cardiometabolic disorders for 12 measures of association, but not for heart failure.
  • Subgroup analysis showed that higher chocolate intake was linked with a 37% reduction in any cardiovascular disease and a 29% reduction in stroke risk, but higher intake was not linked with a reduced risk for heart failure.
  • 1 study showed that higher chocolate intake was linked with a 31% reduced risk for diabetes.
  • There was no significant publication bias.
  • Limitations of the analysis include limited generalizability, heterogeneity in types and amounts of chocolate intake, and inaccuracy in reporting chocolate intake.

Clinical Implications

  • Higher chocolate intake is related to a decreased risk for cardiometabolic disorders overall in 5 of 7 studies.
  • Higher chocolate intake is related to a reduced risk for cardiovascular disease by 37%, diabetes by 31%, and stroke by 29%. There is no link between chocolate intake and heart failure.

CME Test